Estrogen dominance, a relative excess of estrogen compared with progesterone, is associated with a higher likelihood of cherry angiomas. Estrogen stimulates angiogenesis, the formation of new small blood vessels, and a cherry angioma is a benign cluster of those vessels sitting just under the skin. When estrogen runs high or unbalanced for a sustained period, more of those vessel clusters form. Cherry angiomas caused by estrogen dominance do not go away on their own, but they are straightforwardly treatable at home.
For the full background on the estrogen-angiogenesis mechanism, see Why Hormones Cause Cherry Angiomas. This article answers the specific question of how estrogen dominance connects to cherry angiomas, what you can and cannot influence, and how to manage the angiomas themselves.
Key takeaways
Estrogen dominance drives cherry angioma formation through the angiogenesis pathway. The angiomas that form do not resolve when hormones rebalance. Removing them requires direct treatment.
- Estrogen dominance is a relative imbalance: estrogen is high compared with progesterone, not necessarily above the normal range in absolute terms.
- Estrogen upregulates VEGF and related growth signals, which cause capillaries near the skin surface to proliferate and cluster into cherry angiomas.
- Life stage (perimenopause, pregnancy), body composition, liver clearance, exogenous hormones, and sustained stress all affect the estrogen-to-progesterone ratio.
- Addressing estrogen dominance may slow new angioma formation. It will not resolve existing ones, because formed blood vessel clusters remain once established.
- At-home removal with a plasma pen is the direct path to clear skin for existing angiomas.
What estrogen dominance actually means
Estrogen dominance does not require abnormally high estrogen in an absolute sense. It describes a relative imbalance: estrogen is high relative to progesterone. When progesterone is low, even a normal estrogen level produces an estrogen-dominant hormonal environment. When estrogen is genuinely elevated and progesterone is simultaneously low, the dominance is more pronounced.
This distinction matters because many people with cherry angiomas are in a phase of hormonal transition, not frank disease. Perimenopause produces exactly this pattern: estrogen fluctuates upward while progesterone declines more consistently. Pregnancy produces a related pattern: estrogen rises sharply through the second and third trimesters. Both create an estrogen-favoring environment. For a closer look at the perimenopause pattern, see Cherry Angiomas and Perimenopause.
The American College of Obstetricians and Gynecologists recognizes estrogen-progesterone balance as central to a range of hormonally-mediated symptoms. Cherry angiomas are one expression of that imbalance at the skin layer. For the broader picture of how hormonal shifts affect the skin across conditions, see the Hormonal Skin Changes hub.
Why estrogen dominance leads to cherry angiomas
The angiogenesis pathway
Estrogen is an angiogenic hormone. Angiogenesis is the biological process of forming new blood vessels. Estrogen upregulates vascular endothelial growth factor (VEGF) and related signaling pathways that prompt capillaries to grow and branch. When that signal runs continuously or at elevated levels, capillaries near the skin surface proliferate. Some of these newly formed capillaries dilate and cluster into the bright-red dome visible as a cherry angioma.
This is the same mechanism at work during pregnancy (where estrogen drives rapid vessel growth supporting the placenta) and during the fluctuating estrogen spikes of perimenopause. The angioma is a benign side effect of a signaling process the body runs for other purposes.
Relative imbalance vs absolute level
Because the trigger is the ratio of estrogen to progesterone, the angiogenesis signal can be active even when estrogen is within the normal laboratory range. This is why some people with cherry angiomas have lab results that look unremarkable: the absolute value of estrogen may be normal, but progesterone is lower than it should be to balance it. The net effect on the VEGF pathway is the same. For context on how this plays out across common hormonal triggers, the full cluster guide at Cherry Angiomas: Locations and Causes maps the full picture.
Contributing factors
Several factors are associated with a more estrogen-dominant hormonal state. Some are modifiable; many are not.
Life stage. Perimenopause and the perimenopausal transition are the most common natural context. Pregnancy is another. Both are physiological, not pathological.
Body composition. Adipose tissue (body fat) is a source of estrogen production independent of the ovaries, through a process called aromatization. Higher body fat levels are associated with higher circulating estrogen. This is a modifiable factor, though it interacts with many other health variables.
Liver clearance. The liver metabolizes and clears estrogen. When liver function is reduced, estrogen clearance slows and circulating levels rise. Alcohol consumption, certain medications, and metabolic conditions can reduce liver clearance efficiency.
Exogenous estrogen. Hormonal birth control and hormone replacement therapy introduce additional estrogen into the system. Some people on these medications notice new cherry angiomas. This is an association, not a reason to stop any medication. Any medication decisions should be made with the prescribing doctor.
Sustained stress. Cortisol (the stress hormone) competes with progesterone in the steroid hormone synthesis pathway. Sustained high cortisol can suppress progesterone production, which shifts the estrogen-to-progesterone ratio toward estrogen dominance without changing estrogen itself.
If several angiomas appeared suddenly in a short period, the eruptive pattern may be at work. See Eruptive Cherry Angiomas: Why Many Appear at Once for the specific explanation and when it warrants a doctor visit.
What you can influence, and what you cannot
What will not remove existing cherry angiomas
Addressing estrogen dominance through diet, lifestyle, or medication adjustments may slow the formation of new cherry angiomas over time. It will NOT cause existing angiomas to resolve. Once a blood vessel cluster has formed, it remains whether or not the hormonal signal that created it is corrected. The American Academy of Dermatology classifies cherry angiomas as benign vascular growths that require active removal if you want them gone. Hormonal balance is the upstream work; treatment is the downstream step.
Influences worth addressing: body composition (where relevant), alcohol reduction to support liver clearance, stress management to support progesterone levels, and open conversation with a prescribing doctor about exogenous estrogen load if cherry angiomas are a concern.
The NIH MedlinePlus skin conditions reference is a useful starting point if you want to understand the broader landscape of benign vascular skin changes and when to seek clinical evaluation.
Managing the angiomas themselves
Cherry angiomas caused by estrogen dominance are benign and do not require treatment for health reasons. If the appearance is the concern, at-home removal is available and predictable.
The OcuraLife Plasma Pen uses controlled plasma energy to address each cherry angioma precisely, without affecting the surrounding skin. A single 5-minute treatment per spot initiates the healing process. A small protective scab forms and falls away naturally between Day 3 and Day 7. Clear skin is visible by Week 2 to Week 3. The pen has 9 power settings, which allows adjustment based on the size of each angioma.
Day 1
Treat and scab forms
5 minutes per angioma. A small protective scab appears the same day. Healing patches cover friction points.
If you are also interested in the broader hormonal picture and the lifestyle and dietary factors that have been studied in the context of estrogen balance, the OcuraLife Hormonal Balance for Blemish-Free Skin e-book covers that ground in one place.
Addressing estrogen dominance is the upstream work. Treating the angiomas that exist is the direct path to clear skin.
The bottom line
Cherry angiomas and estrogen dominance are connected through the angiogenesis pathway: excess estrogen relative to progesterone upregulates the signals that form new blood vessels, and some of those vessels cluster into cherry angiomas. Life stage, body composition, liver clearance, exogenous hormones, and sustained stress are all factors in how estrogen-dominant a hormonal environment becomes. The cherry angiomas that form during this state do not resolve when hormones rebalance. Addressing the upstream estrogen load is reasonable; treating the existing angiomas directly is the reliable path to clear skin.
28,000+
Customers served
90 days
Risk-free trial
At home
No clinic, no appointment
FAQ
Frequently asked questions
Common questions about cherry angiomas and estrogen dominance, answered with the specific detail that most searches return in incomplete fragments.
↓ Tap each question to reveal the answer.
Built for this
The OcuraLife Plasma Pen is built for this
Delivers focused plasma energy precisely to each cherry angioma. Nine power settings. A scab forms, falls off on its own between Day 3 and Day 7, and the skin renews by Week 2 to 3.
See the Plasma Pen